Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

[1]  K. Shimamoto.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 (JSH2014) , 2014 .

[2]  M. Litwin,et al.  Guidelines for the Management of Hypertension , 2015 .

[3]  Amy Earley,et al.  Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier , 2011, Annals of Internal Medicine.

[4]  R. Agarwal.  Rebuttal: CON Position. People with Chronic Kidney Disease Should Have a Blood Pressure Lower than 130/80 mm Hg , 2010, American Journal of Nephrology.

[5]  R. Toto.  Rebuttal: PRO Position. People with Chronic Kidney Disease Should Have a Blood Pressure Lower than 130/80 mm Hg , 2010, American Journal of Nephrology.

[6]  F. Luft.  Editorial Perspective. The Low Down on Down Low , 2010, American Journal of Nephrology.

[7]  Debate: CON Position. People with Chronic Kidney Disease Should Have a Blood Pressure Lower than 130/80 mm Hg , 2010, American Journal of Nephrology.

[8]  R. Toto.  Debate: PRO Position. People with Chronic Kidney Disease Should Have a Blood Pressure Lower than 130/80 mm Hg , 2010, American Journal of Nephrology.

[9]  Keith C. Norris,et al.  Intensive blood-pressure control in hypertensive chronic kidney disease. , 2010, The New England journal of medicine.

[10]  J. Lewis.  Blood pressure control in chronic kidney disease: is less really more? , 2010, Journal of the American Society of Nephrology : JASN.

[11]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[12]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[13]  C. Rosendorff,et al.  Evidence for Aggressive Blood Pressure–Lowering Goals in Patients with Coronary Artery Disease , 2010, Current atherosclerosis reports.

[14]  W. Elliott.  Treatment blood pressure targets for hypertension , 2010 .

[15]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[16]  S. Tanenbaum.  Pay for performance in Medicare: evidentiary irony and the politics of value. , 2009, Journal of health politics, policy and law.

[17]  M. I. Perez,et al.  Treatment blood pressure targets for hypertension. , 2009, The Cochrane database of systematic reviews.

[18]  H. Black,et al.  Evidence for a lower target blood pressure for people with heart disease , 2009, Current opinion in cardiology.

[19]  Supplemental Tables,et al.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). , 2009, Kidney international. Supplement.

[20]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[21]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[22]  Should subgroup analysis of randomized clinical trials have a direct impact on clinical practice? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Lau,et al.  Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review , 2006, Annals of Internal Medicine.

[24]  Keith C. Norris,et al.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Merlin C. Thomas,et al.  The CARI guidelines. Prevention of progression of kidney disease. , 2006, Nephrology.

[26]  G. Beck,et al.  The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.

[27]  G. Remuzzi,et al.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.

[28]  P. Rothwell.  Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.

[29]  Bruce Kupelnick,et al.  K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease , 2004 .

[30]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[31]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[32]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[33]  T. Peters,et al.  Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. , 2001, Health technology assessment.

[34]  P. Sleight.  Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! , 2000, Current controlled trials in cardiovascular medicine.

[35]  A. Levey,et al.  Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. , 1997, Hypertension.

[36]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[37]  T. Greene,et al.  Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. , 1995, Annals of internal medicine.

[38]  G. Beck,et al.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.

[39]  L. Hunsicker,et al.  Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. , 1991, Controlled clinical trials.